Northwell Health Staff Receives One in a Million Award: In Recognition of the Care They Provided During NY COVID-19 Pandemic

September 14, 2020

Northwell Health staff are being honored with Multiplying Good’s One in a Million Award in recognition of the care they provided during New York’s coronavirus disease 2019 (COVID-19) pandemic.

At Northwell, our tireless and dedicated staff treated more than 77,000 people when New York was the COVID-19 epicenter. They worked through and beyond exhaustion to care for people in need,” said Michael Dowling, Northwell Health President and CEO. “I am humbled by our staff’s unyielding grit and compassion and I am proud that they are being recognized with this award.”

Northwell’s frontline staff cared for more COVID-19 patients than any other US health system and did so under heroic circumstances. From emergency medical technicians who manned the ambulances to phlebotomists deployed to drive-thru testing sites, caregivers at hospitals and environmental services workers who kept everything clean, it was a true team effort.

The One in a Million Awards Campaign celebrates the millions whose acts of bravery, generosity, and kindness are bringing the nation together in this time and, through recognition, inspire others to do the same. Awardees are featured on the campaign’s website and social media, and provided a digital certificate.

“Since our founding in 1972, we have celebrated extraordinary public service with all recipients filtered through a robust selection process,” explained Hillary Schafer, CEO of Multiplying Good. “During this time, millions are leaning in to do anything they can to help, and everyone is looking for good news stories. We believe that every act, at this time, is extraordinary. This campaign is designed for everyone to nominate anyone who inspires them.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version